First Bank : Form 8-K~Current Report
FEDERAL DEPOSIT INSURANCE CORPORATION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to...
Source: marketscreener.com
📰 Current Report News
Page 138 - Current Report News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Current Report. Real-time updates on events, politics, business and more.
Target Global Acquisition I : Private Placement
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT ...
Source: marketscreener.com
Smart Powerr : Change in Certifying Accountants
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or...
Source: marketscreener.com
Vertical Capital Income Fund Announces Appointment of Carlyle as Investment Manager and Rebrand to Carlyle Credit Income Fund
/PRNewswire/ -- Vertical Capital Income Fund (NYSE: VCIF) ("VCIF" or the "Company") today announced that it has changed its corporate name from VCIF to Carlyle...
Lauren Basmadjian New York Stock Exchange Time Payment To Company Shareholders Of Record York Stock Exchange Exchange Commission Company Board Of Trustees
Source: prnewswire.com
FB Financial : Reports Second Quarter 2023 Results
FB Financial Corporation Reports Second Quarter 2023 Results Reports Q2 Diluted EPS of $0.75, Adjusted Diluted EPS* of $0.77 NASHVILLE,...
United States Christophert Holmes Jeaniem Rittenberry Michael Mettee Fb Financial Corporation Company Annual Report On Form
Source: marketscreener.com
Freedom Acquisition I : Material Agreement
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ...
Cayman Islands United States New York New York Stock Exchange Adam Gishen Strategy Master Fund Polar
Source: marketscreener.com
Korro Bio and Frequency Therapeutics Announce Merger Agreement
Merger to create a Nasdaq-listed genetic medicines company focused on advancing Korro Bio’s wholly owned portfolio of RNA editing programs Lead program is a disease modifying therapy for patients with alpha-1 antitrypsin deficiency (AATD), with preclinical data showing an increase of normal A1AT protein to 85% of total protein in circulation Combined company is expected to have cash balance of approximately $170 million at close, which is expected to provide cash runway through several value...
Source: marketscreener.com
Arcturus Therapeutics : Regulation FD Disclosure
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT ...
Source: marketscreener.com
Alro S A : Current report in compliance with of article no. 108 of Law no. 24/2017, republished (ALRO S.A. & Vimetco Extrusion SRL)
Fri, 07/14/2023 - 17:59 Significant event to be reported:Reporting of transactions with related parties according to art. 108paragraph 3 and paragraph 13 of Law no. 24/2017 -...
Marian Daniel Nastase Gheorghe Financial Supervisory Authority Alro Group Current Report Financial Statements Chief Executive Officer
Source: marketscreener.com